MRCP Part 1 → Haematology
Haematology accounts for roughly 5% of the MRCP Part 1 blueprint. This bank has 134 items tagged to it.
Around 5% of the paper, per MRCP(UK) examination blueprints and regulations. That weighting is why the DocPasser mock builder samples sections in proportion rather than shuffling everything into one pile — practising a flat distribution trains you for a paper that does not exist.
A 20-year-old man with known sickle cell disease presents with fever, pleuritic chest pain and breathlessness during a painful crisis. Oxygen saturation is 89%, and a chest radiograph shows new bilateral infiltrates. What is the most likely diagnosis?
The point: Sickle cell disease is an autosomal recessive haemoglobinopathy in which a point mutation produces haemoglobin S, which polymerises when deoxygenated and deforms red cells into sickle shapes that haemolyse and occlude small vessels. It presents with a chronic haemolytic anaemia and recurrent painful vaso-occlusive crises, precipitated by cold, dehydration, infection and hypoxia. The acute chest syndrome (fever, chest pain, hypoxia and new infiltrates) is a leading cause of death and needs urgent oxygen, analgesia, antibiotics and often exchange transfusion. Other crises are the aplastic crisis (parvovirus B19 causing a sudden drop in haemoglobin with a low reticulocyte count) and splenic sequestration. Functional hyposplenism from repeated infarction increases the risk from encapsulated organisms, so vaccination and penicillin prophylaxis are given. Long-term care includes hydroxycarbamide, which raises fetal haemoglobin and reduces crises, transfusion in selected cases, and screening for the chronic organ damage of stroke, pulmonary hypertension, retinopathy and renal disease. An acute painful crisis is managed with prompt analgesia (often strong opioids), hydration, oxygen and treatment of any precipitant.
Source: British Society for Haematology — sickle cell disease guidelines British Society for Haematology · tier 2, specialty society or college
A 20-year-old man with known sickle cell disease presents with fever, pleuritic chest pain and breathlessness during a painful crisis. Oxygen saturation is 89%, and a chest radiograph shows new bilateral infiltrates. What is the most appropriate investigation?
The point: Sickle cell disease is an autosomal recessive haemoglobinopathy in which a point mutation produces haemoglobin S, which polymerises when deoxygenated and deforms red cells into sickle shapes that haemolyse and occlude small vessels. It presents with a chronic haemolytic anaemia and recurrent painful vaso-occlusive crises, precipitated by cold, dehydration, infection and hypoxia. The acute chest syndrome (fever, chest pain, hypoxia and new infiltrates) is a leading cause of death and needs urgent oxygen, analgesia, antibiotics and often exchange transfusion. Other crises are the aplastic crisis (parvovirus B19 causing a sudden drop in haemoglobin with a low reticulocyte count) and splenic sequestration. Functional hyposplenism from repeated infarction increases the risk from encapsulated organisms, so vaccination and penicillin prophylaxis are given. Long-term care includes hydroxycarbamide, which raises fetal haemoglobin and reduces crises, transfusion in selected cases, and screening for the chronic organ damage of stroke, pulmonary hypertension, retinopathy and renal disease. An acute painful crisis is managed with prompt analgesia (often strong opioids), hydration, oxygen and treatment of any precipitant.
Source: British Society for Haematology — sickle cell disease guidelines British Society for Haematology · tier 2, specialty society or college
A 20-year-old man with known sickle cell disease presents with fever, pleuritic chest pain and breathlessness during a painful crisis. Oxygen saturation is 89%, and a chest radiograph shows new bilateral infiltrates. What is the most appropriate management?
The point: Sickle cell disease is an autosomal recessive haemoglobinopathy in which a point mutation produces haemoglobin S, which polymerises when deoxygenated and deforms red cells into sickle shapes that haemolyse and occlude small vessels. It presents with a chronic haemolytic anaemia and recurrent painful vaso-occlusive crises, precipitated by cold, dehydration, infection and hypoxia. The acute chest syndrome (fever, chest pain, hypoxia and new infiltrates) is a leading cause of death and needs urgent oxygen, analgesia, antibiotics and often exchange transfusion. Other crises are the aplastic crisis (parvovirus B19 causing a sudden drop in haemoglobin with a low reticulocyte count) and splenic sequestration. Functional hyposplenism from repeated infarction increases the risk from encapsulated organisms, so vaccination and penicillin prophylaxis are given. Long-term care includes hydroxycarbamide, which raises fetal haemoglobin and reduces crises, transfusion in selected cases, and screening for the chronic organ damage of stroke, pulmonary hypertension, retinopathy and renal disease. An acute painful crisis is managed with prompt analgesia (often strong opioids), hydration, oxygen and treatment of any precipitant.
Source: British Society for Haematology — sickle cell disease guidelines British Society for Haematology · tier 2, specialty society or college
Clinical sciences · Clinical pharmacology and therapeutics · Cardiology · Respiratory medicine · Gastroenterology and hepatology · Neurology · Endocrinology, diabetes and metabolic medicine · Renal medicine · Infectious diseases · Rheumatology · Psychiatry · Dermatology · Geriatric medicine · Oncology · Medical ophthalmology · Palliative medicine and end of life care